Loading...
Header Logo
Keywords
Last Name
Institution

Charles Birbara

Concepts (81)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arthritis, Rheumatoid
8
2015
232
1.120
Why?
Antirheumatic Agents
7
2015
114
1.040
Why?
Antibodies, Monoclonal
6
2013
684
0.480
Why?
Tumor Necrosis Factor-alpha
5
2015
494
0.460
Why?
Low Back Pain
2
2011
97
0.390
Why?
Sulfones
1
2003
22
0.310
Why?
Cyclooxygenase Inhibitors
1
2003
30
0.300
Why?
Isoenzymes
1
2003
134
0.300
Why?
Pyridines
1
2003
83
0.290
Why?
Osteoarthritis, Knee
2
2013
49
0.260
Why?
Treatment Outcome
7
2015
2566
0.230
Why?
Pain
2
2013
217
0.230
Why?
Disability Evaluation
2
2015
153
0.230
Why?
C-Reactive Protein
2
2015
170
0.190
Why?
Adult
11
2015
9524
0.190
Why?
Aged
9
2015
7519
0.190
Why?
Middle Aged
11
2015
9740
0.180
Why?
Methotrexate
3
2006
71
0.180
Why?
Severity of Illness Index
4
2015
831
0.180
Why?
Immunoconjugates
2
2006
43
0.180
Why?
Viscosupplements
1
2013
2
0.150
Why?
Methylprednisolone
1
2013
17
0.150
Why?
Hyaluronic Acid
1
2013
23
0.150
Why?
Adrenal Cortex Hormones
1
2013
45
0.150
Why?
Male
11
2015
17006
0.140
Why?
Female
11
2015
18511
0.140
Why?
Analgesics, Non-Narcotic
1
2011
26
0.130
Why?
Receptor, Nerve Growth Factor
1
2010
4
0.130
Why?
Double-Blind Method
5
2013
457
0.120
Why?
Humans
12
2015
33661
0.110
Why?
Injections, Intravenous
3
2013
151
0.100
Why?
Pneumococcal Vaccines
1
2007
14
0.100
Why?
Influenza Vaccines
1
2007
43
0.090
Why?
Managed Care Programs
1
2005
90
0.080
Why?
Cyclooxygenase 2 Inhibitors
1
2003
24
0.080
Why?
Prostaglandin-Endoperoxide Synthases
1
2003
27
0.080
Why?
Cyclooxygenase 2
1
2003
54
0.080
Why?
Quality of Life
1
2006
451
0.070
Why?
Pain Measurement
2
2013
185
0.060
Why?
Chronic Disease
1
2003
536
0.060
Why?
Drug Therapy, Combination
3
2005
339
0.060
Why?
Injections, Subcutaneous
2
2013
53
0.060
Why?
Adolescent
2
2006
3938
0.050
Why?
Membrane Proteins
1
2003
654
0.050
Why?
Aged, 80 and over
3
2013
2813
0.050
Why?
Matrix Metalloproteinase 3
1
2013
8
0.040
Why?
Injections, Intra-Articular
1
2013
10
0.040
Why?
Ferritins
1
2013
27
0.040
Why?
Antimicrobial Cationic Peptides
1
2013
44
0.040
Why?
Interleukin-6
1
2013
233
0.030
Why?
Nerve Growth Factor
1
2011
4
0.030
Why?
Paresthesia
1
2010
2
0.030
Why?
Drug Administration Schedule
1
2011
216
0.030
Why?
Headache
1
2010
36
0.030
Why?
Respiratory Tract Infections
1
2010
52
0.030
Why?
Walking
1
2010
109
0.030
Why?
Prospective Studies
1
2013
1612
0.030
Why?
Inflammation
1
2013
659
0.030
Why?
Hemagglutination Inhibition Tests
1
2007
15
0.020
Why?
Dose-Response Relationship, Immunologic
1
2007
59
0.020
Why?
Antibody Formation
1
2007
104
0.020
Why?
Antibodies, Bacterial
1
2007
127
0.020
Why?
Sickness Impact Profile
1
2006
32
0.020
Why?
International Cooperation
1
2006
61
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2007
404
0.020
Why?
Infusions, Parenteral
1
2005
21
0.020
Why?
Antibodies, Viral
1
2007
212
0.020
Why?
Infection
1
2005
59
0.020
Why?
Drug Utilization Review
1
2005
52
0.020
Why?
Survival Analysis
1
2005
372
0.020
Why?
Proportional Hazards Models
1
2005
465
0.020
Why?
Dose-Response Relationship, Drug
1
2005
697
0.020
Why?
Enzyme Precursors
1
2003
10
0.020
Why?
Matrix Metalloproteinase 1
1
2003
6
0.020
Why?
Collagenases
1
2003
17
0.020
Why?
Metalloendopeptidases
1
2003
28
0.020
Why?
Multivariate Analysis
1
2005
717
0.020
Why?
Fatigue
1
2003
55
0.020
Why?
Combined Modality Therapy
1
2003
248
0.020
Why?
Follow-Up Studies
1
2005
1510
0.020
Why?
Time Factors
1
2005
2591
0.010
Why?
Birbara's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_